| Target Price | $306.00 |
| Price | $106.96 |
| Potential | 186.09% |
| Number of Estimates | 24 |
| 24 Analysts have issued a price target Nebius 2027 . The average Nebius target price is $306.00. This is 186.09% higher than the current stock price. The highest price target is $430.50 302.49% , the lowest is $145.44 35.98% . | |
| A rating was issued by 30 analysts: 21 Analysts recommend Nebius to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Nebius stock has an average upside potential 2027 of 186.09% . Most analysts recommend the Nebius stock at Purchase. |
27 Analysts have issued a sales forecast Nebius 2026 . The average Nebius sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
23 Analysts have issued an Nebius EBITDA forecast 2026. The average Nebius EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
25 Nebius Analysts have issued a net profit forecast 2026. The average Nebius net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citigroup |
Buy
➜
Buy
|
Unchanged | Nov 16 2026 |
| DA Davidson |
Neutral
➜
Neutral
|
Unchanged | Nov 13 2026 |
| Rosenblatt |
Buy
➜
Buy
|
Unchanged | Nov 13 2026 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Nov 13 2026 |
| Truist Securities |
Buy
➜
Buy
|
Unchanged | Nov 13 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Nov 04 2026 |
| Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | Oct 21 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Nov 16 2026 |
|
Unchanged
DA Davidson:
Neutral
➜
Neutral
|
Nov 13 2026 |
|
Unchanged
Rosenblatt:
Buy
➜
Buy
|
Nov 13 2026 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Nov 13 2026 |
|
Unchanged
Truist Securities:
Buy
➜
Buy
|
Nov 13 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Nov 04 2026 |
|
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
Oct 21 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


